These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. New anti-HIV agents and targets. De Clercq E Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088 [TBL] [Abstract][Full Text] [Related]
12. Pyrazole NNRTIs 1: design and initial optimisation of a novel template. Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880 [TBL] [Abstract][Full Text] [Related]
13. Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase. Zhou Z; Madrid M; Evanseck JD; Madura JD J Am Chem Soc; 2005 Dec; 127(49):17253-60. PubMed ID: 16332074 [TBL] [Abstract][Full Text] [Related]
14. Slow-, tight-binding HIV-1 reverse transcriptase non-nucleoside inhibitors highly active against drug-resistant mutants. Cancio R; Mai A; Rotili D; Artico M; Sbardella G; Clotet-Codina I; Esté JA; Crespan E; Zanoli S; Hübscher U; Spadari S; Maga G ChemMedChem; 2007 Apr; 2(4):445-8. PubMed ID: 17323401 [No Abstract] [Full Text] [Related]
15. Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series. Mai A; Artico M; Sbardella G; Quartarone S; Massa S; Loi AG; De Montis A; Scintu F; Putzolu M; La Colla P J Med Chem; 1997 May; 40(10):1447-54. PubMed ID: 9154967 [TBL] [Abstract][Full Text] [Related]
16. [d4U]-butyne-[HI-236] as a non-cleavable, bifunctional NRTI/NNRTI HIV-1 reverse-transcriptase inhibitor. Hunter R; Muhanji CI; Hale I; Bailey CM; Basavapathruni A; Anderson KS Bioorg Med Chem Lett; 2007 May; 17(9):2614-7. PubMed ID: 17317163 [TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors. Pelemans H; Esnouf R; De Clercq E; Balzarini J Mol Pharmacol; 2000 May; 57(5):954-60. PubMed ID: 10779379 [TBL] [Abstract][Full Text] [Related]
18. Docking of non-nucleoside inhibitors: neotripterifordin and its derivatives to HIV-1 reverse transcriptase. Zhou Z; Madrid M; Madura JD Proteins; 2002 Dec; 49(4):529-42. PubMed ID: 12402361 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase. Gavriliu D; Fossey C; Ciurea A; Delbederi Z; Sugeac E; Ladurée D; Schmidt S; Laumond G; Aubertin AM Nucleosides Nucleotides Nucleic Acids; 2002; 21(8-9):505-33. PubMed ID: 12484448 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Qin H; Liu C; Guo Y; Wang R; Zhang J; Ma L; Zhang Z; Wang X; Cui Y; Liu J Bioorg Med Chem; 2010 May; 18(9):3231-7. PubMed ID: 20371182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]